Skip to Content

Zyprexa Relprevv Approval History

FDA Approved: Yes (First approved December 11, 2009)
Brand name: Zyprexa Relprevv
Generic name: olanzapine
Dosage form: for Extended Release Injectable Suspension
Company: Lilly
Treatment for: Schizophrenia

Zyprexa Relprevv (olanzapine) is a long-acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia.

Development History and FDA Approval Process for Zyprexa Relprevv

DateArticle
Dec 14, 2009Approval FDA Approves Lilly's Zyprexa Relprevv for Treatment of Schizophrenia in Adults

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide